12月16日 - ** 摩根士丹利将美国国防公司诺斯罗普-格鲁曼NOC.N的目标价从720美元下调至714美元，维持 "增持 "评级
** 新的目标价与上次收盘价相比仍有24%的上涨空间
** 券商认为诺斯罗普-格鲁曼公司的核现代化项目、B-21隐形轰炸机和哨兵导弹与美国维持大国地位的目标高度一致
** 然而，券商认识到 B-21 项目潜在费用的持续风险，这可能在短期内对该股造成负面影响
** 24家券商中有14家给予该股 "买入 "或更高评级，10家给予 "持有 "评级；根据LSEG汇编的数据，他们的PT中值为673.5美元。
** 截至上一交易日收盘，股价累计上涨 22.7
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.